Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › COLL
EVENTIDE ASSET MANAGEMENT, LLC position in COLL
COLLEGIUM PHARMACEUTICAL INC · Health Care
EVENTIDE ASSET MANAGEMENT, LLC reported holding 1,361,228 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$49.3M, representing 0.66% of its reported portfolio and ranking #49 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EVENTIDE ASSET MANAGEMENT, LLC's COLL position evolved
EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in COLL in Q3 2023 at 2,631,334 shares (US$58.8M). The position peaked in Q1 2024 at 2,634,041 shares, worth US$102.3M. Across 12 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 1,361,228 shares valued at US$49.3M — a reduction of -63,054 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.63M | $58.81M | New |
| Q4 2023 | 2.63M | $80.97M | Hold |
| Q1 2024 | 2.63M | $102.25M | Hold |
| Q2 2024 | 2.63M | $84.84M | Hold |
| Q3 2024 | 2.64M | $101.83M | Hold |
| Q4 2024 | 2.64M | $75.60M | Hold |
| Q1 2025 | 2.64M | $78.79M | Hold |
| Q2 2025 | 2.64M | $78.11M | Hold |
| Q3 2025 | 2.39M | $83.65M | Reduce |
| Q4 2025 | 1.88M | $86.88M | Reduce |
| Q1 2026 | 1.42M | $47.08M | Reduce |
| Q2 2026 | 1.36M | $49.27M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COLL and 13F data
COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 32 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M), SILVERBACK ASSET MANAGEMENT LLC (US$18.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COLL
- TENOR CAPITAL MANAGEMENT Co., L.P. 68.81M sh · $85.79M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 744.89K sh · $26.92M · Q2 2026
- SILVERBACK ASSET MANAGEMENT LLC 15.30M sh · $18.79M · Q2 2026
More on EVENTIDE ASSET MANAGEMENT, LLC
FAQ
How long has EVENTIDE ASSET MANAGEMENT, LLC held COLL?
EVENTIDE ASSET MANAGEMENT, LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is EVENTIDE ASSET MANAGEMENT, LLC's current position in COLL?
As of Q2 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 1.36M shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $49.27M, representing 0.66% of its reported portfolio and ranking #49.
Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling COLL?
In the latest 13F filing (Q2 2026), EVENTIDE ASSET MANAGEMENT, LLC reduced its position in COLL. The position peaked in Q1 2024 at 2.63M shares.
Which other funds hold COLL?
Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., GOLDENTREE ASSET MANAGEMENT LP, SILVERBACK ASSET MANAGEMENT LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.